KRTAP13-2: A Potential Drug Target and Biomarker (G337959)

Target Name: KRTAP13-2

NCBI ID: G337959

KRTAP13-2: A Potential Drug Target and Biomarker

Keratin-associated protein 13-2 (KRTAP13-2) is a protein that has been identified as a potential drug target and biomarker for various diseases, including cancer. Its unique structure and subcellular localization in the cell have made it an attractive target for drug developers. In this article, we will explore the biology of KRTAP13-2, its potential as a drug target, and its potential as a biomarker for various diseases.

Structure and Localization

KRTAP13-2 is a 21-kDa protein that is expressed in most tissues of the body. It is highly expressed in the brain and testes, and its level is also elevated in various diseases, including cancer. KRTAP13-2 is localized to the periphyton of the brain and is involved in the formation and maintenance of the periphytonal myelin sheath.

KRTAP13-2 plays a critical role in the development and maintenance of the periphytonal myelin sheath. It is involved in the production of the myelin sheath, which is the outermost layer of the neuron and is responsible for transmitting electrical signals. The myelin sheath is composed of two layers, the inner layer, which is composed of the axon, and the outer layer, which is composed of the periphyton.

KRTAP13-2 is involved in the production and localization of the myelin sheath. It is a key regulator of the myelin sheath, and its absence or dysfunction have been implicated in various diseases, including cancer.

Potential Drug Target

KRTAP13-2 is a potential drug target due to its unique structure and localization. Its high expression in the brain and testes, and its involvement in the development and maintenance of the periphytonal myelin sheath make it an attractive target for small molecules that can modulate its activity.

One of the potential drug targets for KRTAP13-2 is the inhibition of its activity, as this can result in the disruption of the myelin sheath and the development of various diseases, including cancer. The inhibition of KRTAP13-2 activity can be achieved through various mechanisms, including inhibition of its catalytic activity, inhibition of its interaction with other proteins, or inhibition of its production.

Potential Biomarker

In addition to its potential as a drug target, KRTAP13-2 is also a potential biomarker for various diseases. Its unique structure and localization make it an attractive target for diagnostic tools, such as antibodies or diagnostic probes.

KRTAP13-2 has been used as a biomarker in various diseases, including cancer. Studies have shown that KRTAP13-2 is highly expressed in cancer tissues and that its expression is associated with the severity of cancer. This suggests that KRTAP13-2 may be a useful biomarker for cancer diagnosis and treatment.

Conclusion

KRTAP13-2 is a protein that has the potential to be a drug target and biomarker for various diseases. Its unique structure and localization make it an attractive target for small molecules that can modulate its activity. Additionally, its involvement in the development and maintenance of the periphytonal myelin sheath makes it an attractive target for diseases that are characterized by the disruption of this sheath, such as cancer.

Future research will be needed to fully understand the biology of KRTAP13-2 and its potential as a drug target and biomarker. Further studies will be necessary to determine the most effective mechanisms of inhibition for KRTAP13-2 and to develop diagnostic tools that can accurately detect its expression in various diseases.

Protein Name: Keratin Associated Protein 13-2

Functions: In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated proteins (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-linking with abundant cysteine residues of hair keratins. The matrix proteins include the high-sulfur and high-glycine-tyrosine keratins (By similarity)

More Common Targets